Assessment of the Global Acquired Hemophilia Treatment Market 2021 to 2029
October 01, 2021 10:03 ET
|
Research and Markets
Dublin, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The "Acquired Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Worldwide Hemophilia Treatment Industry to 2026 - by Manufacturers, Regions, Technology, Application and Product Type
September 01, 2021 05:18 ET
|
Research and Markets
Dublin, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type"...
Global $24.07 Billion Bleeding Disorders Drugs Markets, Competition Forecast & Opportunities, 2026 - Recombinant Coagulation Factor Concentrates Dominated the Market with 52.91% Share in 2020
April 19, 2021 06:53 ET
|
Research and Markets
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Global Bleeding Disorders Drugs Market, By Drug Type (Plasma-derived Coagulation Factor Concentrates, Desmopressin, Others), By Disease Type, By...
Global Hemophilia Treatment Market is Expected to Witness a CAGR of 4.02% During 2018-2024: Energias Market Research Pvt. Ltd.
June 04, 2018 02:18 ET
|
Energias Market Research
NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- The global hemophilia treatment market was estimated at USD 11.65 billion in 2017 and is expected to reach USD 15.85 billion in 2024 at a CAGR of 4.02%...